You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, November 2013
|
| DOI | 10.1186/2051-1426-1-s1-p43 |
| Authors |
Andres Forero, Mehdi Hamadani, Thomas Kipps, Michelle Fanale, Antonio Cuneo, Jaime Perez de Oteyza, Douglas Gladstone, Marc Andre, Naresh Bellam, Trishna Goswami, Ramy Ibrahim, Amy Schneider, Meina Liang, Steven Eck, Nairouz Elgeioushi, Ronald Herbst, Bruce D Cheson |
Mendeley readers
The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 2 | 50% |
| Lecturer | 1 | 25% |
| Other | 1 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 25% |
| Biochemistry, Genetics and Molecular Biology | 1 | 25% |
| Agricultural and Biological Sciences | 1 | 25% |
| Medicine and Dentistry | 1 | 25% |